What Researchers Did
The author ran a controlled trial of hyperbaric oxygen therapy (HBO) for multiple sclerosis (MS) and used it to test how well two health questionnaires, the General Health Questionnaire (GHQ) and the Nottingham Health Profile (NHP), capture patient-reported change.
What They Found
This controlled trial of HBO for multiple sclerosis found that neither the GHQ nor the NHP appeared sensitive to the kinds of significance the author was looking at in reported benefit. The abstract gives no sample size, no treatment pressure, no number of sessions and no statistics. It says the NHP in particular might have a role in identifying orders of effectiveness that more commonly used measures of perceived improvement do not pick up.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract reports no numerical results, no participant numbers and no HBO treatment details, and it says the NHP "might" have a role, so its conclusions about the questionnaires are tentative.